Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for more than 2½ yearsFDA requires drug to show long-term shel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback